Single-nuclei RNA-seq data analysis of human livers at different stages of MASLD [11] showed increased GRHL2-expressing hepatocytes in end-stages of the disease (i.e., cirrhosis and liver failure) when compared to healthy control livers (S12A–S12D Fig). The gene discussed is GRHL2; the disease is Cirrhosis.